HCP Verify PRC ID | eXtend Program

Welcome to eXtend Program

To subscribe , please verify your PRC ID

TERMS AND CONDITIONS

By subscribing to eXtend Program the undersigned agrees to be bound by these Terms and Conditions.
The program shall provide disease-related educational materials, patient medication adherence reminders, patient support, and access program that could come in the form of free medicines.
A doctor who, after consultation and diagnosis, opts to prescribe Tofacitinib (Xeljanz XR) [“The Product”] to a patient, may choose to introduce the program to the patient. If the patient so desires, the patient may accept by filling out the enrollment form, executing and providing consent and calling eXtend Program Hotline, for further instructions.
In accordance with these Terms and Conditions, the program offers free medicines to qualified patients. To qualify, patients must pass the financial screening.
eXtend Counsellor will request supporting financial documents to assess and validate patient eligibility for the eXtend Program.
Patient shall be responsible for submitting any guarantee letter, or any similar document providing or confirming the source of funding that the patient will use to fill its prescription. The authorized dispensing pharmacy, which participates in the implementation of the Program, shall be solely responsible for receiving, evaluating, and determining honoring and use of any guarantee letter, or similar document.
Patients who are successfully enrolled in the program shall receive monthly allocation of free medicines with corresponding purchase based on their approved financial tier level, purchased and free goods shall total a maximum of 60 days’ therapy. Patients may go back after 60 days to purchase and claim any units unfilled in the valid prescriptions.
- A valid prescription, which is one whose prescribed number of units is more than or equal to the lapsed number of days from prescription date. (Example A - Valid Prescription: Prescription Date = Jan 1, 2022; Request date= April 1, 2022. Equivalent # of days 90. Units in Rx=90. Example B - Invalid Prescription: same dates as above but unit in Rx= 60. 60 is less than 90 days, thus invalid.)
Patients will be asked for additional documents (ex. travel documents) if they need more than two months allocation for travel.
Patients are required to present their valid government ID, unique ID code, eXtend code, and a valid prescription (A valid prescription has an issuance date of less than or equal to 3 months from the date of purchase) at the point of purchase in selected pharmacies that will be communicated by eXtend Counsellor
All patient enrollment and transaction requests are NOT automatically approved and guaranteed as they are all subject for assessment and verification by eXtend Counsellor. Patient should provide all required details and submit all duly-signed required documents to qualify.
The number of free tablets will be based on the approved patient tier, treatment duration based on prescription, terms and conditions of the program as agreed by the patient.
All eXtend Code issued by eXtend Counsellor shall be valid for 1 month from creation date of eXtend code.
eXtend code unused after 30 days from issuance shall be invalidated. Such invalidation will be communicated via the patient’s enrolled contact information by the eXtend Program Hotline.
The eXtend Counsellor shall monitor patients requests for monthly allocation and provide regular updates and patient educational materials.
Patient membership is automatically deactivated after 12 months of no program transaction. Patient data is still in the system and patient may call eXtend Program Hotline for assistance/reactivation.
In the event of deactivation, all patient support from the eXtend program shall cease and the patient no longer benefits from this program.
The program only aims to enhance compliance, provide educational content, navigation, and SMS/Call/Email reminders. This program does not replace the advice of your health care provider. If symptoms persist, consult your doctor.
Free medicines received by the patient are for the purpose of enhancing patient medication adherence and compliance. Free goods received should not be sold or misused.
Patients who have valid prescriptions for the product and are currently enrolled in the program will still qualify if their HCP unsubscribes from the program after patient enrollment.
Patients can cancel enrollment at any time by calling the eXtend Program Hotline: (02) 8662-2514, 0917-6232862 (Globe) & 0939-1382626 (Smart) / Email: [email protected]
Program runs from February 2023 until the program is terminated.
Pfizer may opt to stop or continue the program, in full or in part, at any time at its own discretion. Pfizer also reserves the right to change the program, its mechanics and benefits, and these terms and conditions, in full or in part, any time. If you do not agree or can not comply, you can deregister at anytime by using unsubscribe button or calling the eXtend Program Hotline.
The eXtend Counsellor shall inform both our partner doctors and member patients through their enrolled contact details in case of any changes in the program.

IMPORTANT

By signing up for this eXtend Program (“Program”), I understand and acknowledge that I may be disclosing my personal information and sensitive personal information (“Information”), which will be collected, maintained, updated, accessed, shared with Pfizer, as well as among of the group of companies to which Pfizer belongs, as well as vendors, providers, consultants, and other third parties with which Pfizer has a legitimate business with, used and otherwise processed in and/or out of the Philippines. To avoid doubt, all these acts shall be hereinafter referred to as “Process” or “Processing”, which shall be in accordance with the definition under the Philippine Data Privacy Act. As part of Processing, my Information may be maintained or stored in an automated database system that is managed by Avanza Inc., the third party provider that Pfizer has engaged to administer and manage the program, and/or in a database system of its affiliates or authorized third parties in connection with and for the purpose of the implementation, improvement, and enhancements of the program, as well as documenting said implementation, and for purposes of recording, monitoring, and otherwise using relevant information on drug/product safety information or adverse effects. I give my consent to Pfizer and its affiliates, directors, officers, employees, advisers, agents, providers, and representatives (the “Authorized Parties”) (a) Processing of my personal information for purposes of implementing, as well as maintaining and improving, the program, whether the Processing be done within or outside of the Philippines; and (b) outsourcing any, some, or all acts covered by Processing of my Information to consultants, vendors, contractors, and service providers. whether the Processing be done within or outside the Philippines, to fully implement the Program pursuant to its internal policies and applicable laws, including but not limited to its documentation, review, evaluation, revision, audit, reporting, and other similar actions or processes relative to implementing the Program; and (c) storing, maintaining, sharing, collating, reporting, submitting, using and otherwise Processing my Information, whether within or outside the Philippines, for such period as would enable and for the purpose of allowing Pfizer to comply with its obligations relative to safety and/or adverse events monitoring and/or reporting, whether pursuant to its internal policies or to its legal obligations whether within or outside of the Philippines. I understand that I can unsubscribe from the Program anytime. The foregoing constitutes my express consent under the applicable confidentiality and data privacy law of the Philippines and other jurisdictions, and agree to hold Pfizer, Avanza Inc., and relevant parties free and harmless from any and all liabilities, claims, damages, and suits of whatever kind and nature that may arise in connection with the implementation and compliance with the authorization which I confer herein. The foregoing is without prejudice to my rights, upon demand, to reasonable access to, as well as correction or removal of my personal information, as well as my right to lodge a complaint before the National Privacy Commission, pursuant to the Data Privacy Act, as well as other applicable laws and regulations on data privacy. Pfizer or the Authorized Third Parties is/are authorized to store my personal information for as long as necessary: (i) for the fulfillment of the purposes provided in this consent and agreement, (ii) for the establishment, pursuance, and defense of legal claims, or (iii) for any legitimate business purposes, or as provided by law, but without prejudice to my right to request for its deletion. By providing my mobile number and/or email address, I hereby confirm and provide consent for Pfizer, its directors, officers, employees, advisers, agents, representatives, or authorized third parties to contact me through said mobile number and/or email address and continue to contact me in for or in connection with any of the Purposes, including not limited to the sending of notifications or announcements, of invitations, of surveys or questionnaires, and the like. I am aware that I may access Pfizer’s Privacy Policy through: [https://www.pfizer.com.ph/privacy-policy] to know more about how Pfizer uses my personal information. I understand that I may unsubscribe anytime via email/phone call to the eXtend Program hotline [email protected] or at (02) 8662-2514, 0917-6232862, and 0939-1382626. I confirm that I am a registered and licensed Healthcare Professional residing and working in the Philippines. Moreover, by providing my mobile number and/or email address, I hereby confirm and provide consent for Pfizer, its employees and/or affiliates, or authorized third parties to send notifications on Pfizer product updates, CME Announcements, Medical Information and contact me through the said mobile number or and/or email address. I understand that I may change the permissions herein given at any time by updating my profile on the profile page.

For any questions, please contact our eXtend hotline at (02) 8662-2514, 0917-6232862 (Globe) & 0939-1382626 (Smart), <8 AM to 5 PM, Mondays to Fridays, excluding weekends and holidays> and [email protected].